Kodiak Sciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

PALO ALTO, Calif.: PALO ALTO, Calif., Jan. 3, 2022 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Monday,...

Click to view original post